Arkema Selects Dotmatics for R&D Digitalization Project
Arkema has selected Dotmatics to implement a unified electronic laboratory notebook (ELN) across its French research sites, involving 800 users over five years, to digitalize and secure diverse R&D workflows, enhance data access and continuity, accelerate chemical and material innovation through advanced analytics and AI, and facilitate internal and external collaboration.
- Agreement will ensure digital continuity and improve access and security of diverse workflows and data.
- Project roll-out to 800 users at Arkema’s research sites in France.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, announced it has been selected by Arkema, a global leader in speciality materials, as its informatics partner in an R&D digitalization project. Implementing Dotmatics’ unified electronic laboratory notebook (ELN) across Arkema’s research sites in France, the agreement covers 800 users and will run over 5 years.
At a time when the Chemical Industry is transforming R&D through digitalizing laboratory workflows, the agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products. The objective is to ensure digital continuity of all experimental data, thus allowing for faster innovation of chemicals and materials driven by statistics, calculation and modelling, and artificial intelligence.
Dotmatics will equip Arkema scientists with a complete ELN solution including experiment capture, entity registration and sample tracking, data retrieval, and full data analytics. The unified platform will accommodate the diversity of Arkema’s workflow across synthetic chemistry, formulation and polymers, allowing researchers to trace, share, secure and exploit all their R&D data internally and will facilitate collaboration with external partners.
Steve Gallagher, CEO of Dotmatics, commented:
“With our shared spirit of collaboration, we are delighted to have been chosen as a partner to implement their R&D digitalization project and we welcome Arkema to the Dotmatics community of global scientific organizations.
Implementing Dotmatics’ ELN will allow Arkema researchers to leverage valuable corporate R&D data. Web-based rapid capture, search and retrieval of data combined with advanced analytics will support global shared decision-making: empowering scientists to innovate.”
Gérard Guilpain, Scientific Director of Digitalization of R&D at Arkema, commented:
“The ELN is a fundamental digital building block for processing experimental results generated in our laboratories. We are happy to have selected Dotmatics, which will allow us to modernize our work approaches and use a cloud infrastructure as a space for digital continuity to gain value more rapidly from the Group’s research data.”
Media Contact Dotmatics
Sarah Jeffery
Zyme Communications
E: sarah.jeffery@zymecommunications.com
T: +44 (0)7771 730 919
Media Contact Arkema
Véronique Obrecht
Arkema
E: veronique.obrecht@arkema.com
T: +33 1 49 00 88 41
Related
Why OneNote Falls Short as a Scientific Lab Notebook — and What to Use Instead
The article explains that while Microsoft OneNote is a convenient and low-cost note-taking tool some researchers use as a makeshift electronic laboratory notebook (ELN), it lacks essential scientific data management features, built-in validation, and structured organization, making it risky and unreliable for accurately capturing, labeling, and searching experimental research data.
Dotmatics Electronic Laboratory Notebook (ELN)
Dotmatics Electronic Laboratory Notebook (ELN) is a secure, cloud-hosted, and intuitive virtual notebook designed by scientists to streamline capturing, storing, searching, and sharing diverse scientific experiments and data types across disciplines, featuring flexible protocols, intelligent dashboards, integration with Dotmatics applications and third-party databases, and support for internal and external collaboration to enhance productivity and data-driven decision making.
Le cahier de laboratoire électronique pour l'entreprise, conçu par des scientifiques pour les scientifiques
Le cahier de laboratoire électronique (ELN) de Dotmatics, conçu par des scientifiques pour des scientifiques, offre un cadre intuitif et sécurisé permettant de capturer, stocker, rechercher et partager divers types de données expérimentales (molécules, réactions, séquences, images, vidéos, texte, données numériques) via des protocoles flexibles, des tableaux de bord intelligents, une intégration avec d'autres applications Dotmatics, et un hébergement cloud favorisant la collaboration interne et externe tout en protégeant rigoureusement la propriété intellectuelle.
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Joining Forces with Insightful Science
Dotmatics and Insightful Science have merged to form the world’s largest cloud-based scientific research R&D platform, combining their software solutions to accelerate innovation, enhance data-driven research workflows, and drive the digital transformation of scientific labs into the Lab of the Future.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.